Biden Rejects New Debate, Defends Virtual Nomination Ahead of DNC
Facing backlash over debate performance and internal dissent, Biden maintains decision on virtual roll call and no further debates
Read moreDetailsFacing backlash over debate performance and internal dissent, Biden maintains decision on virtual roll call and no further debates
Read moreDetailsThe former president's legal victory arrives at a crucial time for him and his base
Read moreDetailsIn recent weeks, two church leaders have been accused of sexually abusing minors; these cases highlight the need for stricter measures to prevent abuse and protect vulnerable individuals in religious communities. Jose Wilfredo Vazquez Cardoza, a 49-year-old former church leader from Uniondale, New York, was arrested and charged with multiple...
Read moreDetailsThe House of Representatives passed the Safeguard American Voter Eligibility (SAVE) Act on Wednesday; the legislation, which mandates proof of citizenship for voter registration, was approved by a vote of 221-198, with all but five Democrats opposing the measure. This initiative is primarily aimed at preventing noncitizens from participating in...
Read moreDetailsFTC Chair Lina Khan argues that these PBMs act as middlemen, jacking up the price of medications
Read moreDetailsPosting to TruthSocial, the former President denounced the Heritage Foundation's policy plan
Read moreDetailsTo those legislators who are urging him to withdraw, the President says: "Go ahead and announce for president. Challenge me at the convention"
Read moreDetailsAs President Joe Biden grapples with increasing scrutiny following a challenging debate performance against former President Donald Trump, the Democratic Party faces a pivotal decision: how to best position itself for the 2024 election. A clear plan forward remains a subject of intense discussion among party leaders and supporters. Top...
Read moreDetailsThe case highlights the ongoing debate about the balance between free speech and responsible content moderation
Read moreDetailsInvestors are constantly on the lookout for the next big opportunity, right now, however, the fervor surrounding obesity drugs is capturing Wall Street’s attention. The meteoric rise of GLP-1 drugs, such as Ozempic and Wegovy has investors scrambling to identify companies poised to replicate their success. Notably, Gilead Sciences, a...
Read moreDetailsVNY Media La Voce di New York © 2016 / 2025 — La testata fruisce dei contributi diretti editoria d.lgs. 70/2017
Main Office: 230 Park Avenue, 21floor, New York, NY 10169 | Editorial Office/Redazione: UN Secretariat Building, International Press Corps S-301, New York, NY 10017 | 112 East 71, Street Suite 1A, New York, NY 10021
VNY Media La Voce di New York © 2016 / 2025
La testata fruisce dei contributi diretti editoria d.lgs. 70/2017
Main Office: 230 Park Avenue, 21floor, New York, NY 10169 | Editorial Office/Redazione: UN Secretariat Building, International Press Corps S-301, New York, NY 10017 | 112 East 71, Street Suite 1A, New York, NY 10021